Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

[Prevalence of Pulmonary Hypertension in Dialysis Patients with End-stage Renal Disease].

Ortwein J, Feustel A, Reichenberger F.

Pneumologie. 2020 Feb 13. doi: 10.1055/a-1069-0691. [Epub ahead of print] German.

PMID:
32053839
2.

Screening for Bronchoscopic Lung Volume Reduction: Reasons for Not Receiving Interventional Treatment.

May N, Niehaus-Gebele C, Reichenberger F, Behr J, Gesierich W.

Lung. 2020 Feb;198(1):221-228. doi: 10.1007/s00408-019-00303-7. Epub 2019 Dec 12.

PMID:
31832749
3.

Pulmonary hypertension due to lung diseases: Updated recommendations from the Cologne Consensus Conference 2018.

Olschewski H, Behr J, Bremer H, Claussen M, Douschan P, Halank M, Held M, Hoeper MM, Holt S, Klose H, Krüger S, Lange TJ, Reichenberger F, Skowasch D, Ulrich S, Wilkens H, Seeger W.

Int J Cardiol. 2018 Dec 1;272S:63-68. doi: 10.1016/j.ijcard.2018.08.043. Epub 2018 Aug 11. Review.

PMID:
30131231
4.

Daily Chronic Intermittent Hypobaric Hypoxia Does Not Induce Chronic Increase in Pulmonary Arterial Pressure Assessed by Echocardiography.

Götschke J, Mertsch P, Kneidinger N, Kauffmann-Guerrero D, Behr J, Huber RM, Reichenberger F, Milger K.

Can Respir J. 2018 Apr 1;2018:9649716. doi: 10.1155/2018/9649716. eCollection 2018.

5.

Taking Another View on Lung Fibrosis.

Silbernagel E, Bondesson D, Behr J, Dinkel J, Reichenberger F.

Am J Respir Crit Care Med. 2018 Apr 1;197(7):947-948. doi: 10.1164/rccm.201708-1683IM. No abstract available.

PMID:
29394081
6.

Pulmonary CCR2+CD4+ T cells are immune regulatory and attenuate lung fibrosis development.

Milger K, Yu Y, Brudy E, Irmler M, Skapenko A, Mayinger M, Lehmann M, Beckers J, Reichenberger F, Behr J, Eickelberg O, Königshoff M, Krauss-Etschmann S.

Thorax. 2017 Nov;72(11):1007-1020. doi: 10.1136/thoraxjnl-2016-208423. Epub 2017 Aug 5.

PMID:
28780502
7.

Inspiratory capacity is not altered in operable chronic thromboembolic pulmonary hypertension.

Richter MJ, Gall H, Wittkämper G, Seeger W, Mayer E, Ghofrani HA, Guth S, Reichenberger F.

Pulm Circ. 2017 Apr-Jun;7(2):543-546. doi: 10.1177/2045893217709763. Epub 2017 May 12.

8.

[Pulmonary hypertension due to chronic lung disease: Recommendations of the Cologne Consensus Conference 2016].

Olschewski H, Behr J, Bremer H, Claussen M, Douschan P, Halank M, Held M, Hoeper MM, Holt S, Klose H, Krüger S, Lange TJ, Reichenberger F, Skowasch D, Ulrich S, Wilkens H, Seeger W.

Dtsch Med Wochenschr. 2016 Oct;141(S 01):S57-S61. Epub 2016 Oct 19. German.

PMID:
27760451
9.

Collapse phenomenon during Chartis collateral ventilation assessment.

Gesierich W, Samitas K, Reichenberger F, Behr J.

Eur Respir J. 2016 Jun;47(6):1657-67. doi: 10.1183/13993003.01973-2015. Epub 2016 Apr 13.

10.

The prognostic relevance of oxygen uptake in inoperable chronic thromboembolic pulmonary hypertension.

Richter MJ, Pader P, Gall H, Reichenberger F, Seeger W, Mayer E, Guth S, Kramm T, Grimminger F, Ghofrani HA, Voswinckel R.

Clin Respir J. 2017 Nov;11(6):682-690. doi: 10.1111/crj.12399. Epub 2015 Nov 3.

PMID:
26470843
11.

Switching to nintedanib after discontinuation of pirfenidone due to adverse events in IPF.

Milger K, Kneidinger N, Neurohr C, Reichenberger F, Behr J.

Eur Respir J. 2015 Oct;46(4):1217-21. doi: 10.1183/13993003.00584-2015. Epub 2015 Sep 4. No abstract available.

12.

The H2S-generating enzymes cystathionine β-synthase and cystathionine γ-lyase play a role in vascular development during normal lung alveolarization.

Madurga A, Golec A, Pozarska A, Ishii I, Mižíková I, Nardiello C, Vadász I, Herold S, Mayer K, Reichenberger F, Fehrenbach H, Seeger W, Morty RE.

Am J Physiol Lung Cell Mol Physiol. 2015 Oct 1;309(7):L710-24. doi: 10.1152/ajplung.00134.2015. Epub 2015 Jul 31.

13.

Carcinoid tumours of the lung and the 'PEPPS' approach: evaluation of preoperative bronchoscopic tumour debulking as preparation for subsequent parenchyma-sparing surgery.

Neuberger M, Hapfelmeier A, Schmidt M, Gesierich W, Reichenberger F, Morresi-Hauf A, Hatz RA, Lindner M.

BMJ Open Respir Res. 2015 Jul 15;2(1):e000090. doi: 10.1136/bmjresp-2015-000090. eCollection 2015.

14.

Sildenafil versus nitric oxide for acute vasodilator testing in pulmonary arterial hypertension.

Milger K, Felix JF, Voswinckel R, Sommer N, Franco OH, Grimminger F, Reichenberger F, Seeger W, Ghofrani HA, Gall H.

Pulm Circ. 2015 Jun;5(2):305-12. doi: 10.1086/680355.

15.

Acute hemodynamic effects of nebulized iloprost via the I-neb Adaptive Aerosol Delivery system in pulmonary hypertension.

Richter MJ, Ghofrani HA, Voswinckel R, Seeger W, Schulz R, Reichenberger F, Gall H.

Pulm Circ. 2015 Mar;5(1):162-70. doi: 10.1086/679722.

16.

Poor sleep quality is associated with exercise limitation in precapillary pulmonary hypertension.

Tiede H, Rorzyczka J, Dumitrascu R, Belly M, Reichenberger F, Ghofrani HA, Seeger W, Heitmann J, Schulz R.

BMC Pulm Med. 2015 Feb 13;15:11. doi: 10.1186/s12890-015-0005-3.

17.

The prognostic significance of inspiratory capacity in pulmonary arterial hypertension.

Richter MJ, Tiede H, Morty RE, Voswinckel R, Seeger W, Schulz R, Ghofrani HA, Reichenberger F.

Respiration. 2014;88(1):24-30. doi: 10.1159/000360481. Epub 2014 May 21.

18.

Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.

Nave AH, Mižíková I, Niess G, Steenbock H, Reichenberger F, Talavera ML, Veit F, Herold S, Mayer K, Vadász I, Weissmann N, Seeger W, Brinckmann J, Morty RE.

Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):1446-58. doi: 10.1161/ATVBAHA.114.303534. Epub 2014 May 15.

PMID:
24833797
19.

Endobronchial therapy with a thulium fiber laser (1940 nm).

Gesierich W, Reichenberger F, Fertl A, Haeussinger K, Sroka R.

J Thorac Cardiovasc Surg. 2014 Jun;147(6):1827-32. doi: 10.1016/j.jtcvs.2013.12.038. Epub 2014 Jan 15.

20.

Glucocorticoids recruit Tgfbr3 and Smad1 to shift transforming growth factor-β signaling from the Tgfbr1/Smad2/3 axis to the Acvrl1/Smad1 axis in lung fibroblasts.

Schwartze JT, Becker S, Sakkas E, Wujak ŁA, Niess G, Usemann J, Reichenberger F, Herold S, Vadász I, Mayer K, Seeger W, Morty RE.

J Biol Chem. 2014 Feb 7;289(6):3262-75. doi: 10.1074/jbc.M113.541052. Epub 2013 Dec 17.

21.

Shunt volume dynamics in stroke patients with patent foramen ovale.

Reichenberger F, Kaps M, Seeger W, Tanislav C.

J Appl Physiol (1985). 2013 Sep 1;115(5):704-7. doi: 10.1152/japplphysiol.00507.2012. Epub 2013 Jun 6.

22.

[Dynamic hyperinflation in pulmonary arterial hypertension: "hyperinflator" and "non-hyperinflator"].

Richter MJ, Voswinkel R, Tiede H, Seeger W, Schulz R, Ghofrani HA, Reichenberger F.

Pneumologie. 2013 May;67(5):280-7. doi: 10.1055/s-0033-1343148. Epub 2013 May 15. German.

23.

Sleep apnea in precapillary pulmonary hypertension.

Dumitrascu R, Tiede H, Eckermann J, Mayer K, Reichenberger F, Ghofrani HA, Seeger W, Heitmann J, Schulz R.

Sleep Med. 2013 Mar;14(3):247-51. doi: 10.1016/j.sleep.2012.11.013. Epub 2013 Jan 20.

PMID:
23340085
24.

Shining pleura.

Reichenberger F, Dreyer T, Hirschburger M, Steiner D.

Am J Respir Crit Care Med. 2012 Oct 15;186(8):e12-3. doi: 10.1164/rccm.201201-0124IM. No abstract available.

PMID:
23071194
25.

HbA1c in pulmonary arterial hypertension: a marker of prognostic relevance?

Belly MJ, Tiede H, Morty RE, Schulz R, Voswinckel R, Tanislav C, Olschewski H, Ghofrani HA, Seeger W, Reichenberger F.

J Heart Lung Transplant. 2012 Oct;31(10):1109-14. doi: 10.1016/j.healun.2012.08.014.

PMID:
22975101
26.

Exercise training improves exercise capacity and quality of life in patients with inoperable or residual chronic thromboembolic pulmonary hypertension.

Nagel C, Prange F, Guth S, Herb J, Ehlken N, Fischer C, Reichenberger F, Rosenkranz S, Seyfarth HJ, Mayer E, Halank M, Grünig E.

PLoS One. 2012;7(7):e41603. doi: 10.1371/journal.pone.0041603. Epub 2012 Jul 25.

27.

Cardiac Troponin I elevation after epileptic seizure.

Sieweke N, Allendörfer J, Franzen W, Feustel A, Reichenberger F, Pabst W, Krämer HH, Kaps M, Tanislav C.

BMC Neurol. 2012 Jul 17;12:58. doi: 10.1186/1471-2377-12-58.

28.

Quality of life in clinically stable adult cystic fibrosis out-patients: associations with daytime sleepiness and sleep quality.

Bouka A, Tiede H, Liebich L, Dumitrascu R, Hecker C, Reichenberger F, Mayer K, Seeger W, Schulz R.

Respir Med. 2012 Sep;106(9):1244-9. doi: 10.1016/j.rmed.2012.06.010. Epub 2012 Jul 6.

29.

Exercise training in pulmonary arterial hypertension associated with connective tissue diseases.

Grünig E, Maier F, Ehlken N, Fischer C, Lichtblau M, Blank N, Fiehn C, Stöckl F, Prange F, Staehler G, Reichenberger F, Tiede H, Halank M, Seyfarth HJ, Wagner S, Nagel C.

Arthritis Res Ther. 2012 Jun 18;14(3):R148. doi: 10.1186/ar3883.

30.

Safety and efficacy of exercise training in various forms of pulmonary hypertension.

Grünig E, Lichtblau M, Ehlken N, Ghofrani HA, Reichenberger F, Staehler G, Halank M, Fischer C, Seyfarth HJ, Klose H, Meyer A, Sorichter S, Wilkens H, Rosenkranz S, Opitz C, Leuchte H, Karger G, Speich R, Nagel C.

Eur Respir J. 2012 Jul;40(1):84-92. doi: 10.1183/09031936.00123711. Epub 2012 Feb 9.

31.

Pulmonary hypertension due to chronic lung disease: updated Recommendations of the Cologne Consensus Conference 2011.

Hoeper MM, Andreas S, Bastian A, Claussen M, Ghofrani HA, Gorenflo M, Grohé C, Günther A, Halank M, Hammerl P, Held M, Krüger S, Lange TJ, Reichenberger F, Sablotzki A, Staehler G, Stark W, Wirtz H, Witt C, Behr J.

Int J Cardiol. 2011 Dec;154 Suppl 1:S45-53. doi: 10.1016/S0167-5273(11)70492-2.

32.

Dynamic hyperinflation during exercise in patients with precapillary pulmonary hypertension.

Richter MJ, Voswinckel R, Tiede H, Schulz R, Tanislav C, Feustel A, Morty RE, Ghofrani HA, Seeger W, Reichenberger F.

Respir Med. 2012 Feb;106(2):308-13. doi: 10.1016/j.rmed.2011.10.018. Epub 2011 Nov 18.

33.

Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features.

Mierau R, Moinzadeh P, Riemekasten G, Melchers I, Meurer M, Reichenberger F, Buslau M, Worm M, Blank N, Hein R, Müller-Ladner U, Kuhn A, Sunderkötter C, Juche A, Pfeiffer C, Fiehn C, Sticherling M, Lehmann P, Stadler R, Schulze-Lohoff E, Seitz C, Foeldvari I, Krieg T, Genth E, Hunzelmann N.

Arthritis Res Ther. 2011;13(5):R172. doi: 10.1186/ar3495. Epub 2011 Oct 21.

34.

Factors associated with shunt dynamic in patients with cryptogenic stroke and patent foramen ovale: an observational cohort study.

Tanislav C, Puille M, Grebe M, Sieweke N, Allendörfer J, Pabst W, Kaps M, Reichenberger F.

BMC Cardiovasc Disord. 2011 Aug 26;11:54. doi: 10.1186/1471-2261-11-54.

35.

Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations.

Pfarr N, Szamalek-Hoegel J, Fischer C, Hinderhofer K, Nagel C, Ehlken N, Tiede H, Olschewski H, Reichenberger F, Ghofrani AH, Seeger W, Grünig E.

Respir Res. 2011 Jul 29;12:99. doi: 10.1186/1465-9921-12-99.

36.

Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients.

Scheidl SJ, Englisch C, Kovacs G, Reichenberger F, Schulz R, Breithecker A, Ghofrani HA, Seeger W, Olschewski H.

Eur Respir J. 2012 Jan;39(1):119-24. doi: 10.1183/09031936.00109710. Epub 2011 Jul 7.

37.

[Pulmonary arterial hypertension].

Reichenberger F, Voswinckel R.

Internist (Berl). 2011 Apr;52(4):405-14; quiz 415. doi: 10.1007/s00108-011-2810-y. German.

PMID:
21331640
38.

Persistent increase in cardiac troponin I in Fabry disease: a case report.

Tanislav C, Feustel A, Franzen W, Wüsten O, Schneider C, Reichenberger F, Rolfs A, Sieweke N.

BMC Cardiovasc Disord. 2011 Jan 31;11:6. doi: 10.1186/1471-2261-11-6.

39.

High frequency of silent pulmonary embolism in patients with cryptogenic stroke and patent foramen ovale.

Tanislav C, Puille M, Pabst W, Reichenberger F, Grebe M, Nedelmann M, Kaps M, Allendörfer J.

Stroke. 2011 Mar;42(3):822-4. doi: 10.1161/STROKEAHA.110.601575. Epub 2011 Jan 21.

PMID:
21257827
40.

Decrease in shunt volume in patients with cryptogenic stroke and patent foramen ovale.

Tanislav C, Kaps M, Jauss M, Stolz E, Pabst W, Nedelmann M, Grebe M, Reichenberger F, Allendoerfer J.

BMC Neurol. 2010 Dec 29;10:123. doi: 10.1186/1471-2377-10-123.

41.

[Pulmonary hypertension due to chronic lung disease. Recommendations of the Cologne Consensus Conference 2010].

Hoeper MM, Andreas S, Bastian A, Claussen M, Ghofrani HA, Gorenflo M, Grohé C, Günther A, Halank M, Hammerl P, Held M, Krüger S, Lange TJ, Reichenberger F, Sablotzki A, Staehler G, Stark W, Wirtz H, Witt C, Behr J.

Pneumologie. 2011 Apr;65(4):208-18. doi: 10.1055/s-0030-1255970. Epub 2010 Dec 22. German.

42.

[Pulmonary hypertension due to chronic lung disease. Recommendations of the Cologne Consensus Conference 2010].

Hoeper MM, Andreas S, Bastian A, Claussen M, Ghofrani HA, Gorenflo M, Grohé C, Günther A, Halank M, Hammerl P, Held M, Krüger S, Lange TJ, Reichenberger F, Sablotzki A, Staehler G, Stark W, Wirtz H, Witt C, Behr J; German Society of Cardiology (DGK), the German Society of Respiratory Medicine (DGP) and the German Society of Pediatric Cardiology (DGPK).

Dtsch Med Wochenschr. 2010 Oct;135 Suppl 3:S115-24. doi: 10.1055/s-0030-1263318. Epub 2010 Sep 22. German.

PMID:
20862620
43.

Intravenous epoprostenol versus high dose inhaled iloprost for long-term treatment of pulmonary hypertension.

Reichenberger F, Mainwood A, Morrell NW, Parameshwar J, Pepke-Zaba J.

Pulm Pharmacol Ther. 2011 Feb;24(1):169-73. doi: 10.1016/j.pupt.2010.06.004. Epub 2010 Jun 25.

PMID:
20601049
44.

Pulmonary hypertension for clinicians: time to call on genetics?

Reichenberger F.

Respiration. 2010;79(4):274-5. doi: 10.1159/000264922. Epub 2009 Dec 7. No abstract available.

45.

Obstructive sleep apnea in a patient with the Melkersson-Rosenthal syndrome.

Eisele HJ, Reichenberger F, Mayer K, Weissmann N, Seeger W, Schulz R.

Sleep Breath. 2010 Sep;14(3):245-7. doi: 10.1007/s11325-009-0309-8. Epub 2009 Oct 28.

PMID:
19862566
46.

[Pulmonary arterial hypertension].

Reichenberger F.

MMW Fortschr Med. 2009 Sep 24;151(39):47-9. German. No abstract available.

PMID:
19831197
47.

[Pulmonary hypertension in hereditary haemorrhagic teleangiectasia].

Reichenberger F, Wehner LE, Breithecker A, Voswinckel R, Mensch O, Schulz R, Ghofrani HA.

Pneumologie. 2009 Nov;63(11):669-74. doi: 10.1055/s-0029-1215111. Epub 2009 Sep 29. German.

48.

[Therapy of pulmonary arterial hypertension].

Voswinckel R, Reichenberger F, Gall H, Seeger W, Grimminger F, Ghofrani HA.

Internist (Berl). 2009 Sep;50(9):1101-2, 1104-9. doi: 10.1007/s00108-009-2336-8. Review. German.

PMID:
19690823
49.

Noninvasive detection of early pulmonary vascular dysfunction in scleroderma.

Reichenberger F, Voswinckel R, Schulz R, Mensch O, Ghofrani HA, Olschewski H, Seeger W.

Respir Med. 2009 Nov;103(11):1713-8. doi: 10.1016/j.rmed.2009.05.004. Epub 2009 Jun 3.

50.

Stress Doppler echocardiography in relatives of patients with idiopathic and familial pulmonary arterial hypertension: results of a multicenter European analysis of pulmonary artery pressure response to exercise and hypoxia.

Grünig E, Weissmann S, Ehlken N, Fijalkowska A, Fischer C, Fourme T, Galié N, Ghofrani A, Harrison RE, Huez S, Humbert M, Janssen B, Kober J, Koehler R, Machado RD, Mereles D, Naeije R, Olschewski H, Provencher S, Reichenberger F, Retailleau K, Rocchi G, Simonneau G, Torbicki A, Trembath R, Seeger W.

Circulation. 2009 Apr 7;119(13):1747-57. doi: 10.1161/CIRCULATIONAHA.108.800938. Epub 2009 Mar 23.

PMID:
19307479

Supplemental Content

Loading ...
Support Center